As the global reproductive health and IVD markets expand in tandem, Human
Chorionic Gonadotropin (HCG) has emerged as a versatile glycoprotein hormone,
serving both clinical therapeutic and diagnostic purposes. With the global HCG
market valued at USD 847 million in 2024 and projected to reach USD 1.317
billion by 2031 at a CAGR of 6.6%, pharmaceutical partners,
fertility clinics, and IVD manufacturers worldwide seek a trusted supplier that
delivers high-quality, multi-scenario Human Chorionic Gonadotropin. Kangyuan, a
leading biopharmaceutical manufacturer with decades of expertise in
urinary-derived APIs, stands out with its dual-purpose formulation technology,
addressing industry pain points of poor adaptability to different application
scenarios while ensuring strict regulatory compliance and tailored solutions for
North America, Europe, Asia-Pacific, and emerging markets.
What distinguishes Kangyuan’s Human Chorionic Gonadotropin is its
innovative dual-purpose formulation, designed to seamlessly adapt to both
clinical therapeutic and IVD diagnostic needs—an advantage that sets it apart
from conventional single-scenario products. For clinical use, our Human
Chorionic Gonadotropin features high bioactivity (no less than 13,000 IU/mg
protein) and ultra-high purity (≥99.2% via HPLC), achieved through a proprietary
low-temperature purification process that preserves the hormone’s native
molecular structure. This ensures efficacy in ovulation induction, luteal phase
support for IVF, and treatment of male hypogonadism. For IVD
applications (such as HCG test strips), we optimize the formulation for high
sensitivity and specificity, ensuring accurate detection of HCG levels in urine
samples, which aligns with the growing demand for home-based diagnostic products.
As a global supplier of Human Chorionic Gonadotropin, Kangyuan excels in
navigating complex regional regulatory frameworks, a critical advantage for
partners seeking seamless market access. In North America, our Human Chorionic
Gonadotropin complies with FDA guidelines: clinical-grade products support BLA
applications, while IVD-grade formulations meet Class II medical device
requirements and 510(k) registration standards, with
comprehensive documentation to streamline market entry. In Europe, we adhere to
EMA regulations for clinical products and IVDR requirements for IVD-grade HCG
(often classified as Class C/D for home use), providing full
technical dossiers and clinical evidence to pass notified body reviews. In
Asia-Pacific, we leverage cost-efficient production to offer competitive
pricing, catering to the region’s growing reproductive health services and IVD
market while maintaining NMPA compliance.
Kangyuan’s competitive edge in Human Chorionic Gonadotropin production lies
in its stable supply chain, scalable capacity, and customer-centric
customization. We source raw materials from a standardized collection network,
ensuring high-quality urine samples to maintain product consistency, and our GMP-certified facilities boast an annual production capacity of
300,000 MIU, capable of fulfilling both small-batch R&D orders and
large-scale commercial supply. Every batch undergoes rigorous testing, including
bioactivity validation, purity analysis, and sensitivity verification,
guaranteeing safety and reliability for both clinical and IVD use. We also offer
flexible customization options, including different potency specifications and
formulations (lyophilized powder for clinical use, bulk API for IVD
manufacturing), tailored to regional market preferences.
As the global Human Chorionic Gonadotropin market grows, driven by rising
infertility rates, increasing demand for home IVD products, and expanding access
to assisted reproductive technologies, Kangyuan remains at
the forefront of innovation. Our ongoing R&D focuses on optimizing
dual-purpose formulations to further enhance sensitivity and bioactivity, while
expanding regulatory compliance to cover emerging markets in Latin America and
the Middle East. Backed by decades of expertise in urinary-derived APIs and a
global presence in 40+ countries, Kangyuan has become a trusted supplier of
Human Chorionic Gonadotropin for pharmaceutical companies, IVD manufacturers,
and healthcare providers worldwide.
Ready to source versatile, regulatory-compliant Human Chorionic
Gonadotropin for clinical or IVD use? Contact Kangyuan today to discuss your
specific requirements, request samples, or learn how our dual-purpose
formulations can elevate your products and support your success in the global
reproductive health and IVD markets.